TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients – A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose

Iron deficiency (ID) and iron deficiency anemia (IDA) are common findings in patients undergoing lipoprotein apheresis (LA). Different intravenous (iv) formulations are used to treat ID in LA patients, however guidelines and data on ID/IDA management in LA patients are lacking. We therefore performe...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Atherosclerosis. Supplements 2015-05, Vol.18, p.199-208
Hauptverfasser:	Schatz, U., Illigens, B.M.W., Siepmann, T., Arneth, B., Siegert, G., Siegels, D., Heigl, F., Hettich, R., Ramlow, W., Prophet, H., Bornstein, S.R., Julius, U.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anemia, Iron-Deficiency - blood Anemia, Iron-Deficiency - diagnosis Anemia, Iron-Deficiency - drug therapy Anemia, Iron-Deficiency - etiology Biomarkers - blood Blood Component Removal - adverse effects Blood Component Removal - methods Drug Administration Schedule Female Ferric carboxymaltose (FCM) Ferric Compounds - administration & dosage Ferric Compounds - adverse effects Ferric Compounds - therapeutic use Ferric gluconate (FG) Ferritins - blood Germany Hematinics - administration & dosage Hematinics - adverse effects Hematinics - therapeutic use Humans Hyperlipoproteinemias - blood Hyperlipoproteinemias - diagnosis Hyperlipoproteinemias - therapy Infusions, Intravenous Iron - blood Iron deficiency Iron deficiency anemia Iron supplementation Lipoprotein apheresis Lipoproteins, LDL - blood Male Maltose - administration & dosage Maltose - adverse effects Maltose - analogs & derivatives Maltose - therapeutic use Middle Aged Prospective Studies Time Factors Transferrin - metabolism Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!